Chularat Hospital Public Stock Current Valuation
CHG-R Stock | THB 2.64 0.02 0.76% |
Valuation analysis of Chularat Hospital Public helps investors to measure Chularat Hospital's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Chularat Hospital's price fluctuation is out of control at this time. Calculation of the real value of Chularat Hospital Public is based on 3 months time horizon. Increasing Chularat Hospital's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chularat Hospital is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chularat Stock. However, Chularat Hospital's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.64 | Real 2.05 | Hype 2.64 | Naive 2.46 |
The real value of Chularat Stock, also known as its intrinsic value, is the underlying worth of Chularat Hospital Public Company, which is reflected in its stock price. It is based on Chularat Hospital's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chularat Hospital's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chularat Hospital Public helps investors to forecast how Chularat stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chularat Hospital more accurately as focusing exclusively on Chularat Hospital's fundamentals will not take into account other important factors: Chularat Hospital Public Company Current Valuation Analysis
Chularat Hospital's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Chularat Hospital Current Valuation | 39.32 B |
Most of Chularat Hospital's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chularat Hospital Public is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Chularat Hospital Public has a Current Valuation of 39.32 B. This is 173.73% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current valuation for all Thailand stocks is 136.5% lower than that of the firm.
Chularat Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chularat Hospital's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chularat Hospital could also be used in its relative valuation, which is a method of valuing Chularat Hospital by comparing valuation metrics of similar companies.Chularat Hospital is currently under evaluation in current valuation category among its peers.
Chularat Fundamentals
Return On Equity | 0.65 | |||
Return On Asset | 0.33 | |||
Profit Margin | 0.34 % | |||
Operating Margin | 0.44 % | |||
Current Valuation | 39.32 B | |||
Shares Outstanding | 11 B | |||
Shares Owned By Insiders | 1.01 % | |||
Shares Owned By Institutions | 4.10 % | |||
Price To Earning | 55.00 X | |||
Price To Book | 5.46 X | |||
Price To Sales | 3.13 X | |||
Revenue | 11.74 B | |||
Gross Profit | 6.12 B | |||
EBITDA | 5.65 B | |||
Net Income | 4.2 B | |||
Cash And Equivalents | 389.99 M | |||
Cash Per Share | 0.04 X | |||
Total Debt | 313.49 M | |||
Debt To Equity | 0.21 % | |||
Current Ratio | 1.25 X | |||
Book Value Per Share | 0.66 X | |||
Cash Flow From Operations | 4.01 B | |||
Earnings Per Share | 0.39 X | |||
Beta | 0.23 | |||
Market Capitalization | 42.46 B | |||
Total Asset | 10.55 B | |||
Retained Earnings | 888 M | |||
Working Capital | 288 M | |||
Current Asset | 1.42 B | |||
Current Liabilities | 1.13 B | |||
Z Score | 82.0 | |||
Annual Yield | 0.04 % | |||
Net Asset | 10.55 B | |||
Last Dividend Paid | 0.26 |
About Chularat Hospital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chularat Hospital Public's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chularat Hospital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chularat Hospital Public based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Chularat Stock
Chularat Hospital financial ratios help investors to determine whether Chularat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chularat with respect to the benefits of owning Chularat Hospital security.